System and method for synthesis of molecular imaging probes including FDG

• US 20040258615A1
• Filed: 04/20/2004
• Published: 12/23/2004
• Est. Priority Date: 04/22/2003
• Status: Abandoned Application

• Current Assignee: Molecular Technologies
• Original Assignee: Molecular Technologies
• Inventors: Collier, Thomas Lee, Padgett, Henry C., Alvord, Charles W., Matteo, Joseph C., Buchanan, Charles Russell
• Application Number:
  US10/827,991
• Publication Number:
  US 20040258615A1
• Time in Patent Office: Days
• US Class Current: 424/1.11
• CPC Class Codes: A61K 51/0402 carboxylic acid carriers, fatty acids amino acids A61K51/0406
• CPC Class Codes: A61K 51/0453 having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
• CPC Class Codes: A61K 51/0455 having six-membered rings with one nitrogen as the only ring hetero atom
• CPC Class Codes: A61K 51/0459 having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
• CPC Class Codes: A61K 51/0491 Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
• CPC Class Codes: B01J 19/0093 Microreactors, e.g. miniaturised or microfabricated reactors laboratory containers with capillary fluid transport in microfabricated channels or chambers B01L3/5027
• CPC Class Codes: B01J 2219/00873 Heat exchange
• CPC Class Codes: B01J 2219/00889 Mixing micromixers B01F33/30
• CPC Class Codes: B01J 2219/00891 Feeding or evacuation
• CPC Class Codes: B01J 2219/0095 Control aspects
• CPC Class Codes: G21G 1/0005 Isotope delivery systems use of radioisotopes as tracers G21H5/02
• CPC Class Codes: G21G 4/08 specially adapted for medical application radiation therapy using radioactive sources A61N5/10
• CPC Class Codes: G21H 5/02 as tracers

Abstract

The invention provides a method and apparatus for preparation of radiochemicals wherein the reaction that couples the radioactive isotope to the reactive precursor to form a positron-emitting molecular imaging probe is performed in a microfluidic environment. The method comprises providing a micro reactor, providing a precursor solution and introducing the precursor solution into the micro reactor, wherein the precursor solution comprises a reactive precursor adapted for reaction with a radioactive isotope and dissolved in an organic solvent, providing a radioactive solution and introducing the radioactive solution into the micro reactor, wherein the radioactive solution comprises a radioactive isotope dissolved in an organic solvent, and uniting the precursor solution with the radioactive solution in a microchannel of the micro reactor enabling the reactive precursor to react with the radioactive isotope as the precursor solution and radioactive solution flow in the microchannel to form a radiochemical in solution.

Claims

1. A method for producing a radiochemical solution in a microfluidic environment, the method comprising:

i) providing a micro reactor comprising a first inlet port, a second inlet port, an outlet port, and at least one microchannel in fluid communication with the first and second inlet ports and the outlet port;

ii) providing a precursor solution and introducing the precursor solution into the first inlet port of the micro reactor, wherein the precursor solution comprises a reactive precursor adapted for reaction with a radioactive isotope and is dissolved in an organic solvent;

iii) providing an radioactive solution and introducing the radioactive solution into the second inlet port of the micro reactor, wherein the radioactive solution comprises a radioactive isotope dissolved in an organic solvent; and

iv) uniting the precursor solution with the radioactive solution in the at least one microchannel of the micro reactor enabling the reactive precursor to react with the radioactive isotope as the precursor solution and radioactive solution flow in the microchannel to form a radiochemical in solution.

2. The method of claim 1, further comprising the step of:

collecting the radiochemical solution from the outlet port of the micro reactor.

3. The method of claim 2, further comprising the step of:

desolvating the radiochemical present in the radiochemical solution.

4. The method of claim 2, further comprising the step of:

deprotecting the radiochemical present in the radiochemical solution.

5. The method of claim 4, further comprising the step of:

purifying the radiochemical present in the radiochemical solution.

6. The method of claim 2, further comprising the step of:

assaying radioactivity of the radiochemical present in the radiochemical solution.

7. The method of claim 1, wherein:

the organic solvent in which the radioactive isotope is dissolved is a polar aprotic solvent.

8. The method of claim 1, wherein:

the organic solvent in which the reactive precursor is dissolved is a polar aprotic solvent.

9. The method of claim 7 or 8, wherein:

the polar aprotic solvent is selected from the group consisting of acetonitrile, acetone, N,N-dimethylformamide (DMF), dimethylsulfoxide (DMSO), and hexamethylphosphoramide (HMPA).

10. The method of claim 1, wherein:

the radioactive isotope is selected from the group consisting of fluoride-18, carbon-11, nitrogen-13, and oxygen-15.

11. The method of claim 10, wherein:

the radioactive isotope is fluoride-18 consisting of a coordination compound comprising a phase transfer catalyst and salt complex.

12. The method of claim 1, wherein:

the reactive precursor is an organic molecule selected from the group consisting of sugars, amino acids, proteins, nucleosides, and nucleotides.

13. The method of claim 1, wherein:

the reactive precursor is an organic molecule having the structure X-R, wherein R is selected from the group consisting of alkyl, substituted alkyl, heterocycle, substituted heterocycle, aryl, substituted aryl, heteroaryl, and substituted heteroaryl; and

X is a nucleophilic leaving group.

14. The method of claim 13, wherein:

X is a halogen or a pseudohalogen.

15. The method of claim 1, wherein:

the reactive precursor and the radioactive solution flow through the micro reactor using a means for applying a positive pressure at least at either the first inlet port or second inlet port.

16. The method of claim 15, wherein:

the means for applying a positive pressure is at least one pump.

17. The method of claim 1, further comprising the step of:

heating the reactive precursor and radioactive solution during said uniting step.

18. The method of claim 1, wherein the micro reactor further comprises:

a first microchannel pathway in fluid communication with the first inlet of the micro reactor,

a second microchannel pathway in fluid communication with the second inlet of the micro reactor,

a third microchannel pathway in fluid communication with the outlet of the micro reactor, and

wherein the first, second and third microchannel pathways intersect.

19. The method of claim 1, wherein the radiochemical solutions contains a radiochemical selected from the group consisting of:

2-deoxy-2-[¹⁸F] fluoro-D-glucose ([¹⁸F]FDG),

6-[¹⁸F] fluoro-L-3,4-dihydroxyphenylalanine ([¹⁸F]FDOPA),

6-[¹⁸F] fluoro-L-meta-tyrosine ([¹⁸F]FMT),

9-[4-[¹⁸F] fluoro-3-(hydroxymethyl)butyl]guanine ([¹⁸F]FHBG),

9-[(3-[¹⁸F] fluoro-1-hydroxy-2-propoxy)methyl]guanine ([¹⁸F]FHPG),

3-(2′

-[¹⁸F] fluoroethyl)spiperone ([¹⁸F]FESP),

3′

-deoxy-3-[¹⁸F] fluorothymidine ([¹⁸F]FLT),

4-[¹⁸F] fluoro-N-[2-[1-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinyl-benzamide ([¹⁸F]p-MPPF),

2-(1-{6-[(2-[¹⁸F] fluoroethyl)(methyl)amino]-2-naphthyl} ethylidine)malononitrile ([¹⁸F]FDDNP),

2-[¹⁸F] fluoro-α

-methyltyrosine, [¹⁸F] fluoromisonidazole ([¹⁸F]FMISO), 5-[¹⁸F] fluoro-2′

-deoxyuridine ([¹⁸F]FdUrd).

20. A method for synthesizing a fluoride-18 labeled radiochemical in a microfluidic environment, the method comprising:

i) providing a micro reactor comprising a first inlet port, a second inlet port, an outlet port, and at least one microchannel in fluid communication with the first and second inlet ports and the outlet port;

ii) providing an organic reactive precursor solution and introducing the organic reactive precursor solution into the first inlet port of the micro reactor, wherein the organic reactive precursor solution comprises a reactive precursor dissolved in an organic solvent and is adapted for reaction with fluoride-18;

iii) providing a fluoride-18 solution and introducing the fluoride-18 solution into the second inlet port of the micro reactor, wherein the fluoride-18 solution comprises fluoride-18 dissolved in an organic solvent; and

iv) uniting the organic reactive precursor solution with the fluoride-18 solution in a confluence of the at least one microchannel of the micro reactor thereby enabling the reactive precursor to react with the fluoride-18 as the organic reactive precursor solution and the fluoride-18 solution flow in the microchannel to form a fluoride-18 labeled radiochemical in solution.

21. The method of claim 20, further comprising the step of:

collecting the fluoride-18 labeled radiochemical solution from the outlet port of the micro reactor.

22. The method of claim 21, further comprising the step of:

desolvating the fluoride-18 labeled radiochemical present in the fluoride-18 labeled radiochemical solution.

23. The method of claim 21, further comprising the step of:

deprotecting the fluoride-18 labeled radiochemical present in the fluoride-18 labeled radiochemical solution.

24. The method of claim 23, further comprising the step of:

purifying the fluoride-18 labeled radiochemical present in the fluoride-18 labeled radiochemical solution.

25. The method of claim 21, further comprising the step of:

assaying the radioactivity of the fluoride-18 labeled radiochemical present in the fluoride-18 labeled radiochemical solution.

26. The method of claim 20, wherein:

the organic solvent in which the fluoride-18 is dissolved is a polar aprotic solvent.

27. The method of claim 20, wherein:

the organic solvent in which the reactive precursor is dissolved is a polar aprotic solvent.

28. The method of claim 26 or 27, wherein:

the polar aprotic solvent is selected from the group consisting of acetonitrile, acetone, N.N-dimethylformamide (DMF), dimethylsulfoxide (DMSO), and hexamethylphosphoramide (HMPA).

29. The method of claim 20, wherein the fluoride-18 further comprises:

a coordination compound consisting of a phase transfer catalyst and salt complex.

30. The method of claim 20, wherein the organic reactive precursor is selected from the group consisting of:

sugars, amino acids, proteins, nucleosides, and nucleotides.

31. The method of claim 20, wherein the organic reactive precursor is an organic molecule having the structure X-R, wherein:

R is selected from the group consisting of alkyl, substituted alkyl, heterocycle, substituted heterocycle, aryl, substituted aryl, heteroaryl, and substituted heteroaryl, and

X is a nucleophilic leaving group.

32. The method of claim 31, wherein:

X is a halogen or a pseudohalogen.

33. The method of claim 20, wherein:

the reactive precursor and the fluoride-18 solution flow through the micro reactor using a means for applying a positive pressure at least at either the first inlet port or second inlet port.

34. The method of claim 33, wherein:

the means for applying a positive pressure is at least one pump.

35. The method of claim 20, further comprising the step of:

heating the organic reactive precursor solution and fluoride-18 solution during said uniting step.

36. The method of claim 20, wherein the micro reactor comprises:

a first microchannel pathway in fluid communication with the first inlet of the micro reactor,

a second microchannel pathway in fluid communication with the second inlet of the micro reactor,

a third microchannel pathway in fluid communication with the outlet of the micro reactor, and

wherein the first, second and third microchannel pathways intersect.

37. The method of claim 20, wherein the fluoride-18 labeled radiochemical solution collected from the micro reactor is selected from the group consisting of:

2-deoxy-2-[¹⁸F] fluoro-D-glucose ([¹⁸F]FDG),

9-[4-[¹⁸F] fluoro-3-(hydroxymethyl)butyl]guanine ([¹⁸F]FHBG),

9-[(3-[¹⁸F] fluoro-1-hydroxy-2-propoxy)methyl]guanine ([¹⁸F]FHPG),

3-(2′

-[¹⁸F] fluoroethyl)spiperone ([¹⁸F]FESP),

3′

-deoxy-3′

-[¹⁸F] fluorothymidine ([¹⁸F]FLT),

4-[¹⁸F] fluoro-N-[2-[1-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinyl-benzamide ([¹⁸F]p-MPPF),

2-(1-{6-[(2-[¹⁸F] fluoroethyl)(methyl)amino]-2-naphthyl}ethylidine)malononitrile ([¹⁸F]FDDNP),

2-[¹⁸F] fluoro-α

-methyltyrosine, [¹⁸F] fluoromisonidazole ([¹⁸F]FMISO), 5-[¹⁸F] fluoro-2′

-deoxyuridine ([¹⁸F]FdUrd), and protected forms thereof.

38. The method of claim 20, wherein the fluoride-18 labeled radiochemical solution collected from the micro reactor is:

2-deoxy-2-[¹⁸F] fluoro-D-glucose ([¹⁸F]FDG).

39. The method of claim 38, wherein the fluoride-18 labeled radiochemical solution collected from the micro reactor is:

a protected form of 2-deoxy-2-[¹⁸F] fluoro-D-glucose ([¹⁸F]FDG).

40. The method of claim 20, wherein the said uniting step is conducted where the water content, by weight, of the [¹⁸F] fluoride solution is 0.25% or less.